ReviewPulmonary therapy2026

Immunometabolic Modulation in Obese Asthma: How GLP-1 Receptor Agonists Could Influence Systemic and Pulmonary Immune Phenotypes.

Helen O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.